Theratechnologies Eulerpool Nyheter

Theratechnologies Aktiens nyheter

Theratechnologies bevakas av många journalister och investerare över hela världen. De senaste Theratechnologies nyheterna samlar vi här.

• 9 januari ·

  Yahoo
  Theratechnologies Provides Update on EGRIFTA SV® Supply
• 10 december ·

  Yahoo
  Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA
• 9 december ·

  Yahoo
  Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer
• 4 december ·

  Yahoo
  Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada
• 26 november ·

  Yahoo
  Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review
• 25 november ·

  Yahoo
  Theratechnologies Inc. (TSE:TH) Has Found A Path To Profitability
• 17 oktober ·

  Yahoo
  Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab
• 17 oktober ·

  Yahoo
  Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance
• 11 oktober ·

  Yahoo
  Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
• 10 oktober ·

  Yahoo
  Theratechnologies Up 12% in U.S. Premarket Trading After Reporting Q3 Swing to Profit